MMP9 and Hepatic fibrosis: In agreement, pro-fibrogenic factors implicated in liver fibrosis, such as TGFβ, COL1α1, matrix metalloproteinase-9 (MMP9), and interferon-α (IFNα), are consistently decreased after using MLN4924.